(+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]ethanol

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]ethanol
• 英文别名: 2-[(3R,4S)-4-(4-chlorophenvl)-1-methyl-piperidin-3-ylmethanesulfinyl]-ethanol；2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfinyl]ethanol
• 化学式: C₁₅H₂₂ClNO₂S
• 分子量: 315.864
• InChiKey: ARKBQPITPAFYCT-PJVSSZTGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  59.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  (+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsulfanyl]acetic acid methyl ester 在 lithium aluminium tetrahydride 、 双氧水 作用下， 以 四氢呋喃 、 水 、 溶剂黄146 为溶剂， 反应 2.5h， 生成 (+)-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methanesulfinyl]ethanol
  参考文献：
  名称：

  [EN] DOPAMINE-, NOREPINEPHRINE- AND SEROTONIN- TRANSPORTER- SELECTIVE HETEROCYCLIC COMPOUNDS AND THEIR THERAPEUTIC APPLICATIONS
  [FR] COMPOSES HETEROCYCLIQUES SELECTIFS VIS-A-VIS DES TRANSPORTEURS DE LA DOPAMINE, DE LA NOREPINEPHRINE ET DE LA SEROTONINE ET LEURS APPLICATIONS THERAPEUTIQUES

  摘要：

  公开号：

  WO2005041875A3

文献信息

• [EN] DOPAMINE-, NOREPINEPHRINE- AND SEROTONIN- TRANSPORTER- SELECTIVE HETEROCYCLIC COMPOUNDS AND THEIR THERAPEUTIC APPLICATIONS<br/>[FR] COMPOSES HETEROCYCLIQUES SELECTIFS VIS-A-VIS DES TRANSPORTEURS DE LA DOPAMINE, DE LA NOREPINEPHRINE ET DE LA SEROTONINE ET LEURS APPLICATIONS THERAPEUTIQUES
  申请人：UNIV GEORGETOWN

  公开号：WO2005041875A3

  公开（公告）日：2005-11-24
• Dopamine-, Norepinephrine- and Serotonin- Transporter-Selective Heterocyclic Compounds and Their Therapeutic Applications
  申请人：Kozikowski P. Alan

  公开号：US20070254918A1

  公开（公告）日：2007-11-01

  One aspect of the invention relates to piperidine compounds that are useful as inhibitors of monoamine transporters. The invention also relates to pharmaceutical compositions, comprising a piperidine compound of the invention. Another aspect of the present invention relates to the use of the aforementioned compounds in a method of treating a disorder of the central nervous system in a mammal.
• US8153657B2
  申请人：——

  公开号：US8153657B2

  公开（公告）日：2012-04-10
• Piperidine-Based Nocaine/Modafinil Hybrid Ligands as Highly Potent Monoamine Transporter Inhibitors:  Efficient Drug Discovery by Rational Lead Hybridization
  作者：Jia Zhou、Rong He、Kenneth M. Johnson、Yanping Ye、Alan P. Kozikowski

  DOI：10.1021/jm040117o

  日期：2004.11.1

  Some piperidine-based nocaine/modafinil hybrid ligands have been designed, synthesized, and found to display an improved potency at all three monoamine transporters and particularly for DAT and/or NET. Some highly active and selective monoamine transporter inhibitors with low nanomolar to subnanomolar potency were identified. Ligands of this type may find important applications as positron emission tomography imaging tools and in the treatment of central nervous system disorders such as depression and sleep apnea.